Drug Repurposing: Challenges and Opportunities
-
Chair(s):
Flora Musuamba,
Co-Chair Modelling and Simulation Working Party, Federal Agency for Medicines and Health Products, Brussels, BelgiumOscar Della Pasqua,
Chair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom -
Session description:
Drug repurposing and translational pharmacology: Lessons learned from COVID-19
Oscar Della Pasqua
Chair Clinical Pharmacology & Therapeutics, University College London, London, United KingdomDrug repurposing in neurological diseases
Robert Pitceathly
Honorary Consultant at The National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, United KingdomBarriers to bring repurposed medicines to paediatric patients
Dr Viviana Giannuzzi
Head of Research Department, Fondazione per la Ricerca, Farmacologica, Gianni Benzi Onlus, ItalyOptimisation of atorvastatin use in the treatment of familial hypercholesterolemia in paediatric patients
Salvator D'Agate
Clinical Pharmacology & Therapeutics, University College London, London, United KingdomDrug repurposing: regulatory experience and expectations
Flora Musuamba
Federal Agency for Medicines and Health Products, Brussels, Belgium
Speakers
-
Flora MusuambaFederal Agency for Medicines and Health Products, Brussels, Belgium
-
Oscar Della PasquaResearch Associate, National Research Council (CNR), Rome, Italy
-
Robert PitceathlyHonorary Consultant at The National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, United Kingdom
Leave A Comment